Emcure receives income-tax penalties totaling Rs. 57.74 crore
As filed · Emcure Pharmaceuticals Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
What happened
FactEmcure Pharmaceuticals has received Income-tax Department orders imposing aggregate penalties of Rs. 57,73,96,732 for financial years 2014-15 through 2020-21. The company said it is evaluating legal remedies, including an appeal before the Appellate Authority.
Why it matters
CapitSignal interpretationLitigation creates a contingent liability that is not in reported profit until it crystallises.
Scale
- 1.1% of FY26 revenue
₹57.74 Cr stated in the filing against ₹5,243.19 Cr revenue (FY26, standalone)
Source: financial_facts · exchange_table
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Order Book
WithdrawnRevenue from operations grew 22.8% to INR 2,580 crore, reflecting strong execution across both domestic and international businesses.
The order book across the different countries should also go up in line with the supplies.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Amount claimed against the company
- Whether a provision has been made
- Next hearing or order date
- I believe that going forward, whether it is Q2, Q3, Q4, you will see the northward movements as far as the Ind (management committed by Q4 FY27)
- I would like to reiterate my confidence in Emcure to deliver low to mid-teen revenue growth in FY27. (management committed by FY27)
Evidence
- Emcure Pharmaceuticals Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- The penalties represent a potentially material regulatory and financial exposure, although the ultimate outcome may depend on the company’s legal challenge.
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%